Azelis and Tagra Biotechnologies Extend Partnership

Israel’s Tagra Biotechnologies has appointed Azelis as the exclusive distributor of its range of Release on Demand (RND) microcapsules for all personal care applications in France and Benelux, with immediate effect. This latest agreement builds on an existing partnership between the two companies in most of Europe as well as in Canada, China, India, Australia and New Zealand.

“Azelis is well placed to increase market penetration in France and Benelux, and Tagra’s patented technology for the encapsulation of actives, UV filters and pigments is a welcome addition to our portfolio to these markets,” said Tony Craske, market segment director of Azelis EMEA.

Tagra describes itself as a leader in RND microencapsulation technology, a method that allows the controlled/immediate release of non-water soluble ingredients, including actives, vitamins, essential oils, flavonoids, silicones, pigments and sunscreens.